Literature DB >> 3767613

Disseminated Curvularia infection. Additional therapeutic and clinical considerations with evidence of medical cure.

N F Pierce, J C Millan, B S Bender, J L Curtis.   

Abstract

A previously reported case of cerebral infection due to Curvularia lunata is more fully described. Medical cure was apparently achieved after 30 months' treatment with amphotericin B. Success was achieved only when the drug was given in a dose of 40 mg, three times per week, and was continued for six months after enhanced computed tomographic scans no longer showed cerebral lesions. Immunologic studies suggested the infection was accompanied by an unexplained defect in cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767613

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Case 5--a 38-year-old man presented to Kijabe Mission Hospital with a swollen, draining right foot.

Authors:  Jon F Fielder; Tobias Otieno; David Solfelt
Journal:  MedGenMed       Date:  2004-04-27

Review 2.  Curvularia geniculata fungal peritonitis: a case report with review of literature.

Authors:  T J Vachharajani; F Zaman; S Latif; R Penn; K D Abreo
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Fatal cerebral phaeohyphomycosis due to Curvularia lunata in an immunocompetent patient.

Authors:  Elliot Carter; Carole Boudreaux
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Optic atrophy due to Curvularia lunata mucocoele.

Authors:  Tai Smith; Tony Goldschlager; Nigel Mott; Tom Robertson; Scott Campbell
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

5.  Curvularia urinary tract infection: a case report.

Authors:  A M Robson; R D Craver
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

6.  Curvularia lunata peritonitis complicating peritoneal dialysis.

Authors:  J O Lopes; S H Alves; J P Benevenga; F B Brauner; M S Castro; E Melchiors
Journal:  Mycopathologia       Date:  1994-08       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.